Strategic Collaborations Opportunity to partner with pharma, biotech, and clinical consortia to embed PharmGKB's pharmacogenomics data into drug development, dosing guidelines, and labeling through licensed data access and integrated APIs.

Grant-Funded Growth NIH-funded programs present a pathway for sponsored data hosting, secure sharing, and collaborative tools for pharmacogenomics research; offer grant-friendly data services and consulting to scale their knowledge platform.

Data Platform Needs As a curation-heavy resource, PharmGKB could benefit from scalable API access, cloud hosting, and advanced search and analytics to streamline genotype-phenotype annotations and cross-linking with literature.

AI-Driven Curation Introduce AI-assisted literature screening, variant prioritization, and semi-automatic annotation to accelerate updates and expand coverage of gene-drug-disease relationships.

Flexible Commercial Model With a small team, they favor cost-effective, managed services and low-friction partnerships; propose tiered data licenses, hosted dashboards, and professional services for rapid onboarding.